Related Experiment Videos
Paediatric primary care in Europe: variation between countries
Diego van Esso1, Stefano del Torso, Adamos Hadjipanayis
1Primary Care Centre Pare Claret, Barcelona, Spain. dvanesso@ono.com
Archives of Disease in Childhood
|April 21, 2010
Summary
European paediatric primary care systems vary significantly in structure, professional involvement, and training. This heterogeneity necessitates further research to assess the effectiveness of different models for child health outcomes.
Area of Science:
- Pediatrics
- Public Health
- Healthcare Systems Analysis
Background:
- Paediatric primary care (PPC) delivery varies across Europe.
- Limited data exists on the specifics of PPC organization, including who provides care and how.
Purpose of the Study:
- To gather comprehensive data on the current state of paediatric primary care across European nations.
Main Methods:
- A survey questionnaire was distributed to delegates in 31 European countries.
- Data collected included information on PPC systems, demographics, involved professionals, and their training.
Main Results:
- Responses from 29 countries revealed diverse PPC models: 41% GP/FD-based, 24% pediatrician-based, 35% combined.
- Paediatrician numbers in primary care varied, and only 51.7% of countries defined paediatric age as 0-18 years.
- Paediatric training duration differed, with some GPs/FDs receiving minimal or no formal paediatric training.
Conclusions:
- Significant heterogeneity exists in European PPC systems, paediatric training, school healthcare, and adolescent care.
- Further research is required to evaluate the efficacy of different PPC models using specific healthcare indicators.
Related Concept Videos
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:11Secondary Healthcare System
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...